9000 Virginia Manor Road
Beltsville, MD 20705
NextCure is a start-up company focused on discovering and developing next generation immunotherapy-based biologics for cancer and other immune-related disorders. NextCure, with its founder at Yale University, is developing proprietary activity and receptor array systems which will enable the identification of specific interactions of human transmembrane proteins, providing the first complete map of cell-to-cell communication in the TME. The company will apply diverse functional screening assays, in multiple immune cell types, to characterize immune responses engendered by these new cell-to-cell communication pathways.